GSK’s profit rose on better-than-expected performance of HIV, cancer and asthma treatments, offsetting lower vaccine demand ...

Gilead Sciences agreed to pay $202 million to settle a whistleblower lawsuit accusing the drugmaker of civil fraud for paying ...

A New York doctor who treated HIV and AIDS patients sued Gilead for violating the False Claims Act with payments to doctors ...

If you support maintaining the U.S. approach to fighting HIV/AIDS, you should welcome the DOGE review to ensure that programs ...

Patients in historically redlined neighborhoods experience significantly longer delays in achieving HIV viral suppression ...

A former top federal health official who served during President Trump’s first term warned that the drastic cuts to the ...

Gilead Sciences on Thursday reported a first-quarter profit, but revenue was flat, as higher sales of drugs for HIV and liver ...

Demonstrators gathered Thursday on the steps of the Department of Health and Human Services (HHS) building for a “die-in” ...

A panelist discusses how the HIV patient population has aged significantly, with the average age in their clinic now ...

Cuts to sexual health clinics could make eliminating new HIV cases in England by 2030 “impossible”, politicians have warned.

Dolutegravir is recommended by the World Health Organization (WHO) for infants, children and adults and is the preferred HIV ...

The Uganda AIDS Commission (UAC) has reported a continued decline in new HIV infections, though the country still falls short ...